Showing results (1-10 of 492) with videos related to
Sort By:
Pageof 50
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola LandgrenClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
The road to treating smoldering multiple myelomaNeha Korde, Sham Mailankody, Ola LandgrenClinical Advances in Hematology & Oncology : H&O|February 6, 2015
Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategiesDickran Kazandjian, Sham Mailankody, Neha Korde, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.Leukemia & Lymphoma|October 21, 2010
Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myelomaSham Mailankody, Esther Mena, Constance M Yuan, et al.Leukemia & Lymphoma|November 7, 2017
CAR T cell therapy for multiple myeloma: where are we now and where are we headed?Arnab Ghosh, Sham Mailankody, Sergio A Giralt, et al.Nature Reviews. Clinical Oncology|January 28, 2015
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Neha Korde, Alexander M Lesokhin, et al.European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.Pageof 50